{
  "meta": {
    "title": "26_Diabetes_In_Pregnancy",
    "url": "https://brainandscalpel.vercel.app/26-diabetes-in-pregnancy-867ef3d1.html",
    "scrapedAt": "2025-11-30T12:29:55.674Z"
  },
  "questions": [
    {
      "text": "Which of the following are not risk factors for developing gestational diabetes?",
      "choices": [
        {
          "id": 1,
          "text": "Family history of diabetes"
        },
        {
          "id": 2,
          "text": "Gestational diabetes in previous pregnancy"
        },
        {
          "id": 3,
          "text": "Persistent glucosuria"
        },
        {
          "id": 4,
          "text": "Obesity in first-degree relatives"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Obesity in first-degree relatives is not a high-risk factor for gestational diabetes mellitus. However,&nbsp;<strong>severe obesity</strong> is a <strong>risk factor</strong> for developing<strong> gestational diabetes</strong>.&nbsp;</p>\n<p>Gestational diabetes mellitus is defined as <strong>carbohydrate intolerance</strong> of variable severity with <strong>onset </strong>or first recognition <strong>during </strong>the present <strong>pregnancy</strong>.&nbsp;</p>\n<p>It usually presents in the <strong>second </strong>or<strong> third trimester</strong>. <strong>More than 50%</strong> of women with GDM ultimately <strong>develop</strong> overt <strong>diabetes </strong>within 20 years.</p>\n<p>It is recommended to screen for gestational diabetes mellitus&nbsp; in the presence of the following <strong>high-risk factors</strong>:</p>\n<ul>\n<li>Severe obesity</li>\n<li>Strong family history of type-2 diabetes</li>\n<li>Previous history of gestational diabetes mellitus</li>\n<li>Impaired glucose metabolism or glucosuria.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1748",
      "difficulty": "medium"
    },
    {
      "text": "You discover that there is evidence of cardiac malformation in a fetus during a routine USG scan at 16 weeks. What is the minimum level of fasting blood sugar at which you can suspect overt diabetes?",
      "choices": [
        {
          "id": 1,
          "text": "106 mg/dL"
        },
        {
          "id": 2,
          "text": "126 mg/dL"
        },
        {
          "id": 3,
          "text": "116 mg/dL"
        },
        {
          "id": 4,
          "text": "130 mg/dL"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Overt diabetes </strong>is when&nbsp;<strong>fasting blood sugar</strong> is <strong>&ge; 126 mg/dl</strong>. Overt diabetics are women who are known to have <strong>diabetes before pregnancy</strong>.&nbsp;</p>\n<p>A patient is said to have overt diabetes if:</p>\n<ul>\n<li>Fasting blood sugar &ge; 126 mg/dL</li>\n<li>A random blood sugar of &ge; 200 mg/dL</li>\n<li>HbA1c of &ge; 6.5%</li>\n</ul>\n<p><strong>The maternal complication of diabetes:</strong></p>\n<ul>\n<li>increased Miscarriage and preterm labor.</li>\n<li>increased incidence of preeclampsia</li>\n<li>polyhydramnios</li>\n<li>prolongation of labor due to shoulder dystocia, operative interference, and cephalo-pelvic disproportion.</li>\n</ul>\n<p><strong>Fetal and Neonatal complications of diabetes:</strong></p>\n<ul>\n<li>fetal macrosomia (birth weight &gt; 4kg)</li>\n<li>congenital malformations - Musculoskeletal, urogenital, and CNS anomalies.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1753",
      "difficulty": "easy"
    },
    {
      "text": "A patient underwent a one-step procedure for gestational diabetes screening. Which of the following statements regarding this procedure is false?",
      "choices": [
        {
          "id": 1,
          "text": "Fasting blood glucose  ≥ 92 mg/dL  is diagnostic"
        },
        {
          "id": 2,
          "text": "100 grams of glucose is given after overnight fast"
        },
        {
          "id": 3,
          "text": "1-hour blood glucose ≥ 180 mg/dL is diagnostic"
        },
        {
          "id": 4,
          "text": "2-hour blood glucose ≥ 153 mg/dL is diagnostic"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In <strong>one-step procedure</strong>, the patient is given <strong>75g of glucose</strong> after an <strong>overnight fast</strong>, and blood glucose is measured hourly for 2 hours. </p>\n<p><strong>Diagnostic criteria</strong> with one-step procedure is as follows:</p>\n<ul>\n<li>Fasting ≥ 92 mg/dL </li>\n<li>1-hour ≥ 180 mg/dL </li>\n<li>2-hour ≥ 153 mg/dL</li>\n</ul>\n<p><strong>In two-step approach</strong> patient is given glucose and subsequent values measured in two separate steps.</p>\n<ul>\n<li>Step 1 - the patient is given <strong>50 grams</strong> of <strong>glucose</strong> and blood glucose is measured after <strong>one hour</strong>. If it is <strong>≥140 mg/dl</strong> then the screen is <strong>positive </strong>and step 2 is done.</li>\n<li>Step 2 - the patient is given <strong>100g</strong> of <strong>glucose</strong> and values measured hourly, for <strong>3 hours</strong>. A diagnosis is made if at least <strong>two values</strong> are high using one of two methods.</li>\n</ul>\n<p><strong>DIPSI</strong> (Diabetes In Pregnancy Societies of India) recommends a <strong>one-step</strong> procedure <strong>without regard</strong> to the time of the <strong>last meal</strong>. Here the patient is given <strong>75 grams</strong> of oral glucose. A blood glucose value of <strong>≥140 mg/dL</strong> after 2-hours is <strong>diagnostic</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1760",
      "difficulty": "easy"
    },
    {
      "text": "A woman at 28 weeks of gestation is started on insulin therapy after being diagnosed with gestational diabetes mellitus. What should be the fasting blood glucose target in her?",
      "choices": [
        {
          "id": 1,
          "text": "<85mg/dl"
        },
        {
          "id": 2,
          "text": "< 100 mg/dl"
        },
        {
          "id": 3,
          "text": "<90 mg/dL"
        },
        {
          "id": 4,
          "text": "<95 mg/dL"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The<strong> target fasting blood glucose</strong> level in a patient with gestational diabetes mellitus is <strong>95 mg/dl.</strong></p>\n<p>In gestational diabetes mellitus, the targets are:</p>\n<ul>\n<li>&nbsp;Fasting &le; 95 mg/dl</li>\n<li>1-h postprandial &le; 140 mg/dl</li>\n<li>2-h postprandial &le; 120 mg/dl</li>\n<li>HbA1c &le; 6.0%.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1771",
      "difficulty": "medium"
    },
    {
      "text": "According to Priscilla White's classification for diabetes in pregnancy, all of the following classes should be managed with insulin except ______",
      "choices": [
        {
          "id": 1,
          "text": "B"
        },
        {
          "id": 2,
          "text": "H"
        },
        {
          "id": 3,
          "text": "A1"
        },
        {
          "id": 4,
          "text": "F"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Class A1 </strong>is managed by<strong> diet therapy</strong>. Other than A1,<strong>&nbsp;all the other&nbsp;classes</strong> are managed by <strong>insulin therapy</strong>.</p>\n<p>Priscilla White's classification for diabetes in pregnancy is not used anymore. It was modified by the American College of Obstetricians and Gynaecologists in 1986.</p>\n<table>\n<tbody>\n<tr>\n<td>Class</td>\n<td>Description</td>\n</tr>\n<tr>\n<td colspan=\"2\">Gestational Diabetes Mellitus</td>\n</tr>\n<tr>\n<td>A1</td>\n<td>Diet-controlled GDM</td>\n</tr>\n<tr>\n<td>A2</td>\n<td>Insulin-controlled GDM</td>\n</tr>\n<tr>\n<td colspan=\"2\">Diabetes Mellitus</td>\n</tr>\n<tr>\n<td>B</td>\n<td>Onset &gt;20y<br />Duration &lt;10y</td>\n</tr>\n<tr>\n<td>C</td>\n<td>Onset 10-19y<br />Duration 10-19y</td>\n</tr>\n<tr>\n<td>D</td>\n<td>Onset &lt;10y<br />Duration &gt;20y<br />Benign retinopathy</td>\n</tr>\n<tr>\n<td>F</td>\n<td>Nephropathy</td>\n</tr>\n<tr>\n<td>R</td>\n<td>Proliferative retinopathy</td>\n</tr>\n<tr>\n<td>H</td>\n<td>Heart disease</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p>Priscilla White was a pioneer in the treatment of diabetes complicating pregnancy.&nbsp;It emphasizes the importance of 3 factors such as the age of patient, duration of diabetes, and presence of vasculopathy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1795",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false regarding the management of hyperglycemia during pregnancy?",
      "choices": [
        {
          "id": 1,
          "text": "Metformin crosses the placenta and has teratogenic effects on the fetus"
        },
        {
          "id": 2,
          "text": "Diet control is the first line management"
        },
        {
          "id": 3,
          "text": "HbA1c monitored at the end of the first trimester and then every 3 months thereafter"
        },
        {
          "id": 4,
          "text": "Insulin is the first line pharmacological agent"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Metformin crosses the placenta</strong>. However, <strong>no teratogenic effects</strong> have been observed as yet.</p>\n<p><strong>Insulin</strong> is the<strong> preferred treatment</strong> in gestational diabetes mellitus because it does not cross the placenta (American Diabetes Association).</p>\n<p>Management of diabetes in pregnancy:</p>\n<ul>\n<li><strong>Preconceptional counseling</strong>:\n<ul>\n<li>To achieve tight control of diabetes before the onset of pregnancy.</li>\n<li>HbA1C level measured to plan pregnancy. </li>\n<li>Appropriate advice about diet and insulin given</li>\n</ul>\n</li>\n<li><strong>Antenatal care</strong> (at monthly intervals up to 20 weeks and thereafter at 2 weeks intervals):\n<ul>\n<li>Diabetic diet—30 Kcal/kg for normal BMI, 24 Kcal/kg for overweight women, and 12 Kcal/kg for morbidly obese women</li>\n<li>Frequent monitoring of blood glucose</li>\n<li>HbA1c determination at the end of the first trimester and then every 3 months thereafter. HbA1c level of ≤6% is desirable</li>\n</ul>\n</li>\n<li><strong>Insulin therapy</strong> - initiated when diabetes is not controlled by diet alone</li>\n<li><strong>Oral hypoglycemic drugs</strong>- glibenclamide and <strong>metformin</strong> are safe.</li>\n</ul>\n<div class=\"page\" title=\"Page 2466\"> </div>\n<div class=\"page\" title=\"Page 2467\"> </div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1812",
      "difficulty": "easy"
    },
    {
      "text": "A primigravida on screening was found to have a fasting blood glucose of more than 100 mg/dl. Which of the following medications will you not prescribe to her?",
      "choices": [
        {
          "id": 1,
          "text": "Glyburide"
        },
        {
          "id": 2,
          "text": "Metformin"
        },
        {
          "id": 3,
          "text": "Insulin"
        },
        {
          "id": 4,
          "text": "Tolbutamide"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Tolbutamide is not&nbsp;used for the&nbsp;treatment of&nbsp;gestational diabetes.&nbsp;</p>\n<p><strong>First-generation sulfonylureas</strong> such as tolbutamide and chlorpropamide&nbsp;can cause&nbsp;<strong>teratogenicity</strong>, neonatal<strong> hypoglycemia, </strong>and fetal <strong>hyperinsulinemia</strong>.</p>\n<p><strong>First-line glycemic control agents </strong>in pregnancy:</p>\n<ul>\n<li>Insulin</li>\n<li>Glyburide&nbsp;</li>\n<li>Metformin&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1784",
      "difficulty": "easy"
    },
    {
      "text": "A primigravida at 30 weeks of gestation is admitted with preterm labour contractions. She was diagnosed with gestational diabetes, on screening. Which of the following tocolytic drugs should be avoided in her?",
      "choices": [
        {
          "id": 1,
          "text": "Magnesium Sulfate"
        },
        {
          "id": 2,
          "text": "Nifedipine"
        },
        {
          "id": 3,
          "text": "Terbutaline"
        },
        {
          "id": 4,
          "text": "Indomethacin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Terbutaline</strong> should be <strong>avoided</strong> in pregnant women with <strong>diabetes</strong>.</p>\n<p>Terbutaline (&beta;-mimetic drugs) given for tocolysis can cause<strong> hyperglycemia, </strong>which can cause <strong>diabetic ketoacidosis.</strong>&nbsp;Factors precipitating ketoacidosis in pregnancy:</p>\n<ul>\n<li>Hyperemesis gravidarum</li>\n<li>Infection</li>\n<li>Non-compliance</li>\n<li>Insulin pump failure</li>\n<li>&beta;-sympathomimetic drugs</li>\n<li>Corticosteroids</li>\n<li>Poor glycemic control</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1809",
      "difficulty": "medium"
    },
    {
      "text": "According to the American college of obstetricians, macrosomia is defined as the fetal birth weight of______.",
      "choices": [
        {
          "id": 1,
          "text": "≥ 3 kg"
        },
        {
          "id": 2,
          "text": "≥ 3.5kg"
        },
        {
          "id": 3,
          "text": "≥ 4.5kg"
        },
        {
          "id": 4,
          "text": "≥5 kg"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>According to the American college of obstetricians (ACOG),<strong> macrosomia</strong> is defined as the fetal birth weight of <strong>≥ 4.5 kg</strong>.</p>\n<p><strong>Macrosomia</strong> refers to<strong> growth beyond </strong>a specific<strong> threshold</strong>, regardless of gestational age. In developed countries, the most commonly used threshold is the weight above 4.5 kg, but weight above 4 kg is also commonly used.</p>\n<p>The<strong> WHO </strong>defines the cut-off at <strong>4.0 kg </strong>for fetal macrosomia in its guidelines for the management of common maternal conditions. This is followed in India.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1773",
      "difficulty": "easy"
    },
    {
      "text": "In gestational diabetes, which of the following is an independent and substantial risk factor for macrosomia?",
      "choices": [
        {
          "id": 1,
          "text": "BMI"
        },
        {
          "id": 2,
          "text": "Glucose intolerance"
        },
        {
          "id": 3,
          "text": "Cord serum c peptide levels"
        },
        {
          "id": 4,
          "text": "HbA1C"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>BMI </strong>(body mass index)<strong>&nbsp;</strong>is an <strong>independent </strong>and <strong>substantial risk factor</strong> for <strong>macrosomia </strong>in both diabetic and non-diabetic mothers.</p>\n<p><strong>BMI levels</strong> are associated with<strong> increased birth weight</strong>, regardless of glucose levels.&nbsp;<strong>Gestational diabetes prevalence</strong> increases by approximately <strong>1 percent</strong> for every <strong>1 kg/m2 increase </strong>in BMI.</p>\n<p><strong>BMI cutoffs</strong> for pregnancy:</p>\n<p>Underweight -&nbsp;&lt; 18&nbsp;kg/m<sup>2&nbsp;</sup></p>\n<p>Normal - 18.5&nbsp;to 24.9&nbsp;kg/m<sup>2</sup>&nbsp;</p>\n<p>Overweight - 25&nbsp;to 29.9&nbsp;kg/m<sup>2</sup>&nbsp;</p>\n<p>Obese - &gt;30&nbsp;kg/m<sup>2</sup>&nbsp;</p>\n<p>Weight distribution also seems to play a role because the risk of gestational diabetes is increased with truncal obesity.&nbsp;<strong>HbA1c levels</strong> are associated with <strong>fetal malformations </strong>in pre-gestational diabetes.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9619",
      "difficulty": "hard"
    },
    {
      "text": "According to ACOG, routine cesarean delivery is advocated in a woman with gestational diabetes mellitus if the sonographically estimated fetal weight is _____ g.",
      "choices": [
        {
          "id": 1,
          "text": ">3000"
        },
        {
          "id": 2,
          "text": ">3500"
        },
        {
          "id": 3,
          "text": ">4000"
        },
        {
          "id": 4,
          "text": ">4500"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>According to the&nbsp;American College of Obstetricians and Gynecologists (ACOG), <strong>routine cesarean</strong> delivery is advocated in a woman with <strong>gestational diabetes mellitus</strong> if the <strong>sonographically</strong> estimated <strong>fetal weight</strong> is<strong> &ge;&nbsp;4500 g</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1792",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant woman has gestational diabetes mellitus (GDM) and her blood glucose levels are well controlled on insulin. What will be the appropriate gestational age for her delivery?",
      "choices": [
        {
          "id": 1,
          "text": "37 weeks"
        },
        {
          "id": 2,
          "text": "39 weeks"
        },
        {
          "id": 3,
          "text": "38 weeks"
        },
        {
          "id": 4,
          "text": "40 weeks"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>most appropriate time</strong> for the delivery in this patient would be <strong>39 weeks</strong> as she has good glycemic control with insulin.</p>\n<p>The<strong> timing for delivery</strong> in a pregnant woman with GDM would vary <strong>depending </strong>on the<strong> control </strong>of <strong>glucose</strong> levels &amp; mode of treatment.</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Appropriate timing for delivery in gestational diabetes</strong></td>\n</tr>\n<tr>\n<td><strong>Well-controlled</strong> with diet</td>\n<td>39 weeks to 40 weeks +6 days</td>\n</tr>\n<tr>\n<td><strong>Well-controlled</strong> with <strong>insulin/oral agent</strong></td>\n<td>39 weeks to 39 weeks + 6 days</td>\n</tr>\n<tr>\n<td><strong>Co-morbidity</strong> or suboptimal control</td>\n<td>Induction before 39 weeks</td>\n</tr>\n<tr>\n<td>With <strong>poor glycemic control</strong></td>\n<td>\n<ul>\n<li>Reasonable to deliver at 37 to 38 weeks + 6 days of gestation &nbsp;</li>\n<li>In extreme cases where all efforts for glycemic control have failed induction prior to 37 weeks (no clear cut guideline )</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7101",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following complications is unlikely in a patient with gestational diabetes?",
      "choices": [
        {
          "id": 1,
          "text": "Abortion"
        },
        {
          "id": 2,
          "text": "Preeclampsia"
        },
        {
          "id": 3,
          "text": "Respiratory distress syndrome"
        },
        {
          "id": 4,
          "text": "Oligohydramnios"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Polyhydramnios</strong> is a <strong>complication</strong> of <strong>diabetes</strong>, not oligohydramnios.</p>\n<p>Gestational diabetes mellitus (GDM) is commonly defined as glucose intolerance first recognized during pregnancy.</p>\n<p>Complications of gestational diabetes:</p>\n<ul>\n<li>Spontaneous abortion</li>\n<li>Preterm labor</li>\n<li>Unexplained fetal demise</li>\n<li>Hypoglycemia</li>\n<li>Malformations</li>\n<li>Altered fetal growth</li>\n<li>Hypocalcemia</li>\n<li>Hypertrophic cardiomyopathy</li>\n<li>Pre-eclampsia</li>\n<li>Respiratory distress syndrome</li>\n<li>Polyhydramnios</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1797",
      "difficulty": "easy"
    },
    {
      "text": "On screening, a primigravida is found to have fasting blood glucose of 110mg/dl. What is the likelihood that she will develop overt diabetes within the next 20 years?",
      "choices": [
        {
          "id": 1,
          "text": "25%"
        },
        {
          "id": 2,
          "text": "40%"
        },
        {
          "id": 3,
          "text": "50%"
        },
        {
          "id": 4,
          "text": "10%"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>50 % </strong>of women with gestational diabetes develop <strong>overt diabetes</strong> within<strong> 20 years.&nbsp;</strong>Hence, they are recommended to undergo screening and revaluation from time to time.</p>\n<p>Fasting blood glucose of&nbsp;&ge; 92 mg/dL indicates gestational diabetes.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1793",
      "difficulty": "hard"
    },
    {
      "text": "A 29-year-old woman with overt diabetes comes to you for pre-conception counseling. Which of the following congenital heart defects are least likely to occur if she were to have a child?",
      "choices": [
        {
          "id": 1,
          "text": "Tetrology of Fallot"
        },
        {
          "id": 2,
          "text": "Transposition of great arteries"
        },
        {
          "id": 3,
          "text": "Ventricular septal defect"
        },
        {
          "id": 4,
          "text": "Double outlet right ventricle"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Tetrology of Fallot (TOF) is usually not seen in infants of diabetic mothers.</p>\n<p><strong>Ventricular septal defect</strong> and <strong>transposition of great arteries</strong> are the <strong>most common</strong> cardiac anomalies in infants of <strong>diabetic mothers</strong>.</p>\n<p>Cardiac defects that present more often in infants of diabetic mothers are:</p>\n<ul>\n<li>Transposition of the great arteries (TGA)</li>\n<li>Double outlet right ventricle (DORV)</li>\n<li>Ventricular septal defect (VSD)</li>\n<li>Truncus arteriosus</li>\n<li>Tricuspid atresia</li>\n<li>Patent ductus arteriosus (PDA)</li>\n</ul>\n<p>The <strong>most common cardiac anomaly</strong> in an infant of a diabetic mother is a controversial topic. Most resources mention <strong>VSD </strong>and <strong>TGA</strong> are the most common and do not specify which among them is more common.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1762",
      "difficulty": "medium"
    },
    {
      "text": "Hypocalcemia in a newborn is defined as serum calcium _____ mg/dl.",
      "choices": [
        {
          "id": 1,
          "text": "< 8"
        },
        {
          "id": 2,
          "text": "< 8.5"
        },
        {
          "id": 3,
          "text": "< 9"
        },
        {
          "id": 4,
          "text": "< 7.5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"page\" title=\"Page 1149\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hypocalcemia</strong> in a newborn is defined as serum calcium <strong>&lt; 8 mg/dl</strong>.</p>\n<p>Hypocalcemia is one of the potential metabolic derangements in <strong>neonates</strong> of <strong>diabetic mothers</strong>.</p>\n<p>There is&nbsp;<strong>hypomagnesemia </strong>in the <strong>mother </strong>and the<strong> infant</strong> due to<strong> increased</strong> maternal<strong> urinary excretion</strong> of <strong>magnesium</strong> due to <strong>diabetes</strong>.&nbsp;There is <strong>maternal hyperparathyroidism</strong> due to hypomagnesemia which leads to <strong>increased maternal calcium</strong>.&nbsp;</p>\n<p>This <strong>maternal calcium </strong>passes to the infant through the placenta and <strong>suppresses fetal PTH </strong>synthesis and <strong>impairs PTH response</strong> to postpartum hypocalcemia.&nbsp;PTH suppression, in this case, can be severe and lead to convulsions in the early neonatal period and may persist for months.</p>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1769",
      "difficulty": "hard"
    },
    {
      "text": "You are performing capillary blood glucose charting for newborns in the post-natal ward. Below what level is it considered hypoglycemia?",
      "choices": [
        {
          "id": 1,
          "text": "<40"
        },
        {
          "id": 2,
          "text": "<45"
        },
        {
          "id": 3,
          "text": "<50"
        },
        {
          "id": 4,
          "text": "<55"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Neonatal hypoglycemia is defined as <strong>blood glucose levels &lt;45 mg/dL.</strong></p>\n<p><strong>Maternal hyperglycemia </strong>stimulates the<strong> fetal pancreas</strong> to secrete <strong>excess insulin</strong>, which causes increased neonatal fat deposition, abdominal girth, and macrosomia (Pederson's hypothesis). It also leads to a rapid drop in plasma glucose concentration after delivery. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA1767",
      "difficulty": "medium"
    },
    {
      "text": "Identify the maternal condition that can lead to the findings in the baby as shown below.",
      "choices": [
        {
          "id": 1,
          "text": "Pre-gestational diabetes"
        },
        {
          "id": 2,
          "text": "Gestational diabetes mellitus"
        },
        {
          "id": 3,
          "text": "Effect of valproate"
        },
        {
          "id": 4,
          "text": "Hypertensive on ACE inhibitors"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The image showing a poorly developed lower limb suggests the diagnosis of&nbsp;<strong>caudal regression sequence/sacral agenesis&nbsp;</strong>seen in&nbsp;<strong>pregestational diabetes</strong>. It is the <strong>most specific</strong> anomaly seen in diabetes.</p>\n<p>The caudal regression sequence is a rare malformation, frequently associated with <strong>maternal pre-gestational diabetes</strong>.&nbsp;It consists of a spectrum of <strong>structural defects</strong> of the caudal region, including incomplete development of the <strong>sacrum</strong> and the <strong>lumbar vertebrae.</strong></p>\n<p>Elevated maternal&nbsp;<strong>HbA1c levels</strong> correlate with fetal malformations.&nbsp;It occurs approximately <strong>200 times</strong> more frequently in<strong> infants </strong>of <strong>diabetic mothers</strong> than in other infants.&nbsp;</p>\n<p><strong>Overt diabetes</strong> (<strong>pregestational diabetes</strong>) is associated with higher malformation rates than the general population.<strong> Neural tube defects</strong> (encephalocele, meningomyelocele, anencephaly), <strong>transposition of great vessels</strong>, ventricular septal defect, atrial septal defect, hypoplastic left heart, aortic stenosis and coarctation of the aorta are commonly seen.&nbsp;</p>\n<p><strong>Small left colon syndrome</strong> is a rare anomaly that develops in the second and third trimesters.</p>\n<p>Option B:&nbsp;<strong>Malformations</strong> are <strong>not associated with gestational diabetes mellitus</strong> (GDM). Malformations occur due to the disruption of organogenesis, usually occurring in the first trimester. The abnormal glycemic status in GDM manifests only in the second trimester.&nbsp;</p>\n<p>Option C:&nbsp;<strong>Valproate</strong> leads to <strong>neural tube defects</strong> and not sacral agenesis.</p>\n<p>Option D:&nbsp;<strong>ACE inhibitors</strong> can cause <strong>oligohydramnios</strong>.</p><hr><h3>Related Pearl: Teratogenic drugs and the birth defects</h3><table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Adverse effects</strong></td>\n</tr>\n<tr>\n<td>Penicillamine</td>\n<td>Cutis laxa syndrome</td>\n</tr>\n<tr>\n<td><strong>Lithium</strong></td>\n<td><strong>Ebstein anomaly</strong></td>\n</tr>\n<tr>\n<td>Isotretinoin</td>\n<td>Facial-ear anomalies, heart disease, CNS anomalies</td>\n</tr>\n<tr>\n<td>Progesterone</td>\n<td>Masculinization of the female fetus</td>\n</tr>\n<tr>\n<td>Quinine</td>\n<td>Abortion, thrombocytopenia, deafness</td>\n</tr>\n<tr>\n<td>Topiramate</td>\n<td>Cleft lip</td>\n</tr>\n<tr>\n<td><strong>Valproate</strong></td>\n<td>Spina bifida, limb defects, <strong>autism spectrum disorder</strong>, facial and cardiac anomalies, <strong>Coarctation of the aorta</strong>, Aortic stenosis, Pulmonary atresia, Ventricular Septal Defect. </td>\n</tr>\n<tr>\n<td><strong>Vitamin D</strong></td>\n<td><strong>Supravalvular aortic stenosis</strong></td>\n</tr>\n<tr>\n<td><strong>Warfarin</strong></td>\n<td>Fetal bleeding, <strong>hypoplastic nasal structures</strong></td>\n</tr>\n<tr>\n<td><strong>Statins</strong></td>\n<td>Vertebral, anal, cardiac, tracheoesophageal fistula, renal, arterial, limb (<strong>VACTERAL</strong>) defects</td>\n</tr>\n<tr>\n<td><strong>Phenytoin</strong></td>\n<td>Ventricular septal defect, Atrial Septal Defect, Coarctation of the aorta, Patent Ductus Arteriosus</td>\n</tr>\n<tr>\n<td>ACE inhibitors and ARBs</td>\n<td>\n<p>Hypoplasia of organs, anuria, irreversible renal failure</p>\n</td>\n</tr>\n<tr>\n<td>Carbimazole and Methimazole</td>\n<td> \n<p>Choanal atresia, aplasia cutis, tracheoesophageal fistula and fetal goiter</p>\n</td>\n</tr>\n<tr>\n<td>Alcohol</td>\n<td>Atrial Septal Defect, Ventricular Septal Defect</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/96ddb0a65c7343a2823a298f353987c7.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0700",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following will be the most effective contraception in a female with hypertension and a history of gestational diabetes mellitus?",
      "choices": [
        {
          "id": 1,
          "text": "Oral contraceptives"
        },
        {
          "id": 2,
          "text": "Intra uterine device"
        },
        {
          "id": 3,
          "text": "Barrier methods"
        },
        {
          "id": 4,
          "text": "DMPA injection"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Intrauterine devices</strong>&nbsp;are the<strong> most effective</strong> contraceptive choice in patients with <strong>gestational diabetes</strong> mellitus and <strong>hypertension</strong>.&nbsp;</p>\n<p>It is suitable in patients with<strong> diabetes</strong> and<strong> comorbidities</strong> like obesity,<strong> hypertension</strong>, or dyslipidemia. It is a method without potential cardiovascular consequences, unlike hormonal contraceptives.</p>\n<p>Low-dose <strong>hormonal contraceptives</strong> can be<strong> used safely</strong> in women with gestational diabetes if there are <strong>no associated comorbidities</strong>.&nbsp;</p>\n<p>Even though the&nbsp;<strong>barrier method </strong>will not lead to complications in such patients, the&nbsp;<strong>failure rate</strong> is<strong> high</strong>&nbsp;due to incorrect use and non-compliance.&nbsp;Hence it is not preferred.</p>\n<p>Option D: DMPA(depot-medroxyprogesterone acetate) is an injectable hormonal contraceptive that is contraindicated in diabetic pregnant women with co-morbidities.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9618",
      "difficulty": "medium"
    }
  ]
}